- Home
- RLAY vs OLP Comparison
RLAY vs OLP Comparison
Compare RLAY & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- OLP
- Stock Information
- Founded
- RLAY 2015
- OLP 1982
- Country
- RLAY United States
- OLP United States
- Employees
- RLAY N/A
- OLP N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- OLP Real Estate Investment Trusts
- Sector
- RLAY Health Care
- OLP Real Estate
- Exchange
- RLAY Nasdaq
- OLP Nasdaq
- Market Cap
- RLAY 490.3M
- OLP 569.9M
- IPO Year
- RLAY 2020
- OLP N/A
- Fundamental
- Price
- RLAY $3.13
- OLP $24.57
- Analyst Decision
- RLAY Strong Buy
- OLP Strong Buy
- Analyst Count
- RLAY 11
- OLP 1
- Target Price
- RLAY $18.40
- OLP $28.00
- AVG Volume (30 Days)
- RLAY 2.2M
- OLP 43.2K
- Earning Date
- RLAY 05-05-2025
- OLP 05-06-2025
- Dividend Yield
- RLAY N/A
- OLP 7.35%
- EPS Growth
- RLAY N/A
- OLP N/A
- EPS
- RLAY N/A
- OLP 1.35
- Revenue
- RLAY $7,679,000.00
- OLP $92,152,000.00
- Revenue This Year
- RLAY N/A
- OLP $11.87
- Revenue Next Year
- RLAY $169.23
- OLP $4.72
- P/E Ratio
- RLAY N/A
- OLP $18.17
- Revenue Growth
- RLAY N/A
- OLP 3.31
- 52 Week Low
- RLAY $1.78
- OLP $22.32
- 52 Week High
- RLAY $10.72
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- RLAY 50.08
- OLP 49.85
- Support Level
- RLAY $2.75
- OLP $23.89
- Resistance Level
- RLAY $3.10
- OLP $24.68
- Average True Range (ATR)
- RLAY 0.20
- OLP 0.45
- MACD
- RLAY 0.01
- OLP 0.08
- Stochastic Oscillator
- RLAY 58.16
- OLP 65.03
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.